Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
C 10.98 -6.63% -0.78
JNCE closed down 6.63 percent on Friday, February 26, 2021, on 64 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical JNCE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bearish Engulfing Bearish 0.00%
Earnings Movers Other 0.00%
20 DMA Resistance Bearish -6.63%
Pocket Pivot Bullish Swing Setup -6.63%
Doji - Bearish? Reversal -6.63%
Earnings Movers Other -6.63%
New Uptrend Bullish -0.27%
Oversold Stochastic Weakness -0.27%
New Downtrend Bearish 0.27%
Older End-of-Day Signals for JNCE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 19 hours ago
Fell Below 10 DMA about 19 hours ago
10 DMA Support about 19 hours ago
20 DMA Resistance about 19 hours ago
Down 5% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Immunology Solid Tumors Immune System Natural Sciences Immunotherapy Monoclonal Antibodies Monoclonal Antibody

Is JNCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.08
52 Week Low 2.85
Average Volume 486,112
200-Day Moving Average 7.49
50-Day Moving Average 9.70
20-Day Moving Average 11.85
10-Day Moving Average 11.23
Average True Range 0.96
ADX 32.15
+DI 23.91
-DI 17.72
Chandelier Exit (Long, 3 ATRs ) 11.20
Chandelier Exit (Short, 3 ATRs ) 12.66
Upper Bollinger Band 13.44
Lower Bollinger Band 10.26
Percent B (%b) 0.23
BandWidth 26.86
MACD Line 0.26
MACD Signal Line 0.51
MACD Histogram -0.2538
Fundamentals Value
Market Cap 437.57 Million
Num Shares 39.9 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 17.48
Price-to-Sales 2.24
Price-to-Book 2.58
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.89
Resistance 3 (R3) 13.06 12.61 12.57
Resistance 2 (R2) 12.61 12.12 12.52 12.46
Resistance 1 (R1) 11.79 11.82 11.57 11.62 12.36
Pivot Point 11.34 11.34 11.22 11.25 11.34
Support 1 (S1) 10.52 10.85 10.30 10.35 9.60
Support 2 (S2) 10.07 10.55 9.98 9.50
Support 3 (S3) 9.25 10.07 9.39
Support 4 (S4) 9.08